Gulin-Sarfraz T, Pryazhnikov E, Zhang J, Khiroug L, Rosenholm J M
Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.
Department of Pharmacy, University of Oslo, Oslo, Norway.
Mater Today Bio. 2019 Jun 12;2:100010. doi: 10.1016/j.mtbio.2019.100010. eCollection 2019 Mar.
We hereby present a concept of scavenging excess imaging agent prior to a diagnostic imaging session, consequently allowing for enhanced contrast of signals originating from the tissue area of interest to the signals originating from systemic imaging agent residues. In our study, a prospective silica core-shell nanoparticle-based scavenger was designed and explored for its feasibility to scavenge a specific imaging agent (tracer) in the bloodstream. The developed tracer-scavenger system was first investigated under conditions to ensure proper binding between tracer and scavenger is taking place, as confirmed by Förster/fluorescence resonance energy transfer studies. , two-photon imaging was utilized to directly study the interaction of the scavenger particles and the tracer molecules in the vasculature of mice. To our knowledge, a methodological solution for differentiation between signals, originating from tissue and blood, has not been presented elsewhere.
我们在此提出一种在诊断成像之前清除过量成像剂的概念,从而使源自感兴趣组织区域的信号与源自全身成像剂残留的信号之间的对比度增强。在我们的研究中,设计了一种基于二氧化硅核壳纳米颗粒的前瞻性清除剂,并探索了其在血液中清除特定成像剂(示踪剂)的可行性。首先在确保示踪剂和清除剂之间发生适当结合的条件下研究了所开发的示踪剂 - 清除剂系统,这一点通过Förster/荧光共振能量转移研究得到了证实。然后,利用双光子成像直接研究清除剂颗粒与示踪剂分子在小鼠脉管系统中的相互作用。据我们所知,尚未在其他地方提出区分源自组织和血液的信号的方法学解决方案。